Hilal El Idrissi Hossam
Faculty of Medicine and Pharmacy of Casablanca, University Hassan II, Morocco.
Gene Rep. 2020 Sep;20:100756. doi: 10.1016/j.genrep.2020.100756. Epub 2020 Jun 15.
The new SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) belongs to the family of coronaviruses, and it is a new strain of coronavirus that has not been previously identified in humans. It causes a contagious disease, which affects the respiratory system and can lead to severe complications in some cases. This virus was detected in China, then rapidly spread to almost all countries. Because of their complexity and the malignancy of the symptoms, they remain a center of interest for researchers. Herein, we provide a review in terms of transmission, clinical presentation, diagnosis, and treatment options in clinical trials of COVID-19 (coronavirus disease 2019), because readers need to update themselves regularly, and there is still much more to know about it.
新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）属于冠状病毒科，是一种此前未在人类中发现的新型冠状病毒株。它会引发一种具有传染性的疾病，影响呼吸系统，在某些情况下还会导致严重并发症。这种病毒在中国被检测到，随后迅速传播到几乎所有国家。由于其复杂性和症状的严重性，它仍然是研究人员关注的焦点。在此，我们对2019冠状病毒病（COVID-19）临床试验中的传播、临床表现、诊断和治疗选择进行综述，因为读者需要定期更新知识，而且关于它仍有许多有待了解的地方。
